NantKwest Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.09 |
Market Cap |
$108.54 M |
Shares Outstanding |
98.67 M |
Public Float |
9.14 M |
Address |
3530 John Hopkins Court San Diego California 92121 United States |
Employees | - |
Website | http://www.nantkwest.com |
Updated | 07/08/2019 |
NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U. |